LLLu Long

Lu Long

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lu Long has a total of 140 co-authors. Here are the top co-authors by number of shared publications:

  • Zhenhua Chen

    Department of Microbiology Laboratory, Chengdu Municipal Center for Disease Control and Prevention, Chengdu, Sichuan, China

    9 shared publications
  • Hongxia Peng

    Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China

    6 shared publications
  • Juan Liao

    Department of Gastroenterology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, 610041, China

    6 shared publications
  • Xiaoxia Duan

    Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University , Chengdu 610041 , China

    6 shared publications
  • Xueling Ren

    Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China

    5 shared publications
  • Xueqin Tang

    Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China

    5 shared publications

Latest Publications

  • Open Access

    Impact of Follow-Up Duration and Geographical Distribution of Whole-Genome Sequencing Studies on Estimates of Exogenous Reinfection in Recurrent Tuberculosis: A Systematic Review and Meta-Analysis

    by Shixun Zhou, Yuemeng Shi, Xi Luo, Yanling Xie, Rongxin Yang, Qifei Song, Dan Xiao, Pengcuo Ciren, Lu Long

    Truncated follow-up and low-resolution genotyping obscure the proportion of exogenous reinfection in recurrent tuberculosis. We aimed to quantify how extended follow-up (≥2 years) and whole-genome sequencing (WGS) affect the estimated proportion of reinfection. We did a systematic review and meta-analysis by searching PubMed, Embase, and Web of Science for English-language studies published between 1 January 2020 and 7 February 2026 that used genotyping techniques to distinguish relapse from reinfection in recurrent tuberculosis, and we integrated these with those from a 2021 meta-analysis that reported a 29% pooled reinfection proportion. Risk of bias was assessed using a modified Newcastle–Ottawa Scale, and random-effects model meta-analyses were conducted to estimate pooled proportions of reinfection. In studies with <2 years of follow-up, the pooled reinfection proportion was 22%. However, when follow-up was extended to ≥2 years, the proportion increased to 34% (95%CI 26–42%), with an adjusted OR of 1.94. Shorter follow-up was associated with a nearly 12% lower observed proportion of exogenous reinfection. Current WGS-related research is mainly concentrated in Asia (50%), especially China (36%), and lacks data from the Americas. The estimated proportion of exogenous tuberculosis reinfection is substantially influenced by follow-up duration and is constrained by the geographical distribution of current WGS data.

  • Metabolomic profiling of telomere length: associations with aging-related phenotypes and modifiable lifestyle factors in Chinese older adults

    by Tianpei Ma, Xunying Zhao, Ke Jiang, Lei Lin, Lanjin Xu, Nan Yang, Xin Chen, Qingwen Zhao, Xingyu Zhang, Haiyu Yan, et al.

    Background: Telomere length (TL) is a well-established biomarker of cellular senescence, yet the metabolic profile of TL and its associations with aging-related phenotypes and responses to modifiable lifestyle factors remain unclear. Methods: TL was measured using quantitative real-time polymerase chain reaction (qPCR) in 282 participants from the West China Health and Aging Cohort (WCHAC). Plasma metabolites were analyzed using liquid chromatography-tandem mass spectrometry. TL-associated metabolic signatures (Met-TL) were identified through elastic net regression models. Associations between Met-TL and aging-related phenotypes and modifiable lifestyle factors were evaluated using linear and logistic regression models in a larger, non-overlapping sample of 5957 WCHAC participants. Furthermore, we employed mediation analysis to explore the mediating effects of Met-TL between lifestyle factors and aging-related diseases. Results: We identified a plasma metabolite signature comprising 26 metabolites explaining 17.5% of TL variance. Met-TL significantly associated with aging-related phenotypes (44 Bonferroni-corrected associations) and modifiable lifestyle factors (4 associations). Notably, Met-TL showed robust associations with steatohepatitis and hepatic biomarkers. Mediation analysis revealed that Met-TL partially explained the protective association between healthy lifestyle and steatohepatitis, with a mediation proportion of 8.2%. Conclusion: These findings provide novel insights into the metabolic profile of TL in older adults. The Met-TL may serve as a promising biomarker of cellular aging, particularly in identifying liver dysfunction, facilitating the development of personalized aging monitoring and anti-aging intervention strategies.

  • Open Access

    Viral shedding dynamics in coxsackievirus A6 hand, foot, and mouth disease: a prospective, individual-level analysis

    by Jiale Meng, Yue Cheng, Zhenhua Chen, Yue Zheng, Ling Ding, Xiaodong Li, Lhakpa Tsamlag, Pengcuo Ciren, Lu Long

    Coxsackievirus A6 (CVA6) has emerged as the predominant cause of hand, foot, and mouth disease (HFMD) in China since the introduction of enterovirus A71 (EV-A71) vaccination. A precise definition of the infectious period is critical for effective containment; however, data on the duration and kinetics of CVA6 shedding remain scarce. We therefore aimed to characterize the viral shedding dynamics of CVA6 and to identify the determinants of viral clearance. We conducted a prospective longitudinal study enrolling pediatric inpatients with laboratory-confirmed CVA6 HFMD between June 2022 and August 2023. Serial pharyngeal swabs were collected every other day during hospitalization and weekly after discharge until two consecutive negative tests were obtained. Shedding duration was analyzed using Kaplan-Meier estimates and Cox proportional hazards models. Viral load was quantified by reverse transcription quantitative polymerase chain reaction (RT-qPCR) and its dynamics were modeled using mixed-effects models. Among 88 patients, the median duration of viral shedding was 16 days (95% CI: 14-22), with more than 50% remaining PCR-positive beyond current isolation recommendations. Viral load levels were highest in the first week following symptom onset and tended to show a general progressive decline over the subsequent 5 weeks. Agranulocytosis was associated with prolonged shedding (HR = 0.41, 95% CI: 0.21-0.81, p = 0.010), whereas lymphocytosis accelerated clearance (HR = 1.83, 95% CI: 1.03-3.25, p = 0.039). Elevated aspartate aminotransferase (AST) level was independently associated with higher viral load (β = 0.016, SE = 0.006, p = 0.012). CVA6 infection is characterized by prolonged viral shedding, which is modulated by host immune and hepatic factors. These findings highlight the need for evidence-based, serotype-specific public health guidelines in the post-EV-A71 vaccine era.

  • Sleep, metabolites, and global cognition: a mediation analysis of plasma metabolic profiles in the West China Health and Aging Cohort

    by Xueyao Wu, Qingwen Zhao, Xingyu Zhang, Haiyu Yan, Xinyang Dui, Ke Jiang, Xin Chen, Lei Lin, Tianpei Ma, Xunying Zhao, et al.

    Background: Growing evidence connects sleep disorders with cognitive impairment in older adults, though underlying biological mechanisms remain unclear. We investigated how plasma metabolic profiles mediate the relationship between sleep patterns and global cognitive function. Methods: In a cross-sectional analysis of 3888 participants aged ≥60 years from the West China Health and Aging Cohort, we analyzed associations between 221 metabolites with both sleep characteristics and cognitive outcomes (assessed via Mini-Mental State Examination), evaluated mediating roles of individual metabolites and composite metabolite scores, and assessed joint associations of genetic susceptibility, sleep patterns, and metabolic profiles with cognitive function. Analyses were adjusted for demographic, lifestyle, comorbidity, and medication factors. Results: We identified 93 metabolites associated with sleep characteristics and 26 linked to cognitive outcomes. Four individual metabolites, including ketoleucine, dodecanoic acid, ribonic acid, and ortho-hydroxyphenylacetic acid, mediated 1.67%-3.25% of the sleep-cognition associations. Composite metabolite scores, both unrestricted and those restricted to branched-chain amino acid (BCAA) pathways, demonstrated stronger mediation effects, with proportions reaching up to 13.6%. Participants with concurrent exposure to poor sleep, high genetic risk, and adverse metabolic profiles showed significantly worse cognitive outcomes compared to those without these risk factors, with effect sizes exceeding those in single or dual exposure groups. Conclusions: Plasma metabolic signatures, particularly those involving BCAA metabolism, may serve as biological intermediaries linking poor sleep to worse cognitive function in older adults and could help identify populations at an elevated risk of cognitive impairment. Longitudinal and experimental studies are required to validate these associations and develop metabolic-based strategies for cognitive preservation.


  • Interplay of accelerated biological aging, lifestyle factors, and genetic susceptibility in cognitive function: a community study

    by Tianpei Ma, Xin Chen, Qingwen Zhao, Xinyin Xu, Xingyu Zhang, Xiaoxue Liu, Diji Zhuoma, Mengjie Hu, Haiyu Yan, Lei Lin, et al.

    Cognitive impairment is a significant health concern in aging populations, but the interplay between biological aging, lifestyle factors, and genetic susceptibility remains unclear. This study examined whether accelerated biological aging is associated with cognitive impairment, whether lifestyle modifies this association, and how genetic background influences these relationships in Chinese older adults. In this cross-sectional study (2022-2023), 7033 participants from southwestern China were included. Accelerated biological aging was calculated as the residual difference between biological age (based on 10 biomarkers) and chronological age. Lifestyle was assessed via a composite index (smoking, alcohol, physical activity, diet, sleep). Cognitive function was measured using the Chinese Mini-Mental State Examination (C-MMSE), and genetic risk was evaluated through polygenic scores and APOE ε4 status. Linear and logistic regression models assessed associations between accelerated aging and cognition. Accelerated biological aging was associated with lower MMSE scores ( β = −0.243, 95% CI: −0.354, −0.133) and higher cognitive impairment prevalence (OR = 1.098, 95% CI: 1.040, 1.158). An unhealthy lifestyle exacerbated cognitive impairment in biologically older individuals (RERI = 0.25). Those with both accelerated aging and unhealthy lifestyle had the lowest MMSE scores ( β = −1.424, 95% CI: −1.846, −1.003) and highest odds of cognitive impairment (OR = 1.467, 95% CI: 1.194, 1.803). These effects were consistent across all genetic background subgroups. Accelerated aging was associated with lower cognitive function, especially in individuals with unhealthy lifestyles, regardless of genetic susceptibility. This highlights lifestyle modification as a potential intervention target for aging-related cognitive impairment.

  • Open Access

    Clinical, aetiological, and epidemiological studies of outpatient cases of hand, foot, and mouth disease in Chengdu, China, from 2019 to 2022: a retrospective study

    by Maoyao Xia, Yu Zhu, Juan Liao, Shirong Zhang, Denghui Yang, Peng Gong, Shihang Zhang, Guiyu Jiang, Yue Cheng, Jiantong Meng, et al.

    The introduction of the Enterovirus A71 (EV-A71) vaccine in China in 2016 has led to a considerable decline in severe hand, foot, and mouth disease (HFMD) cases, with mild outpatient instances now representing the majority of HFMD cases in the country. Nevertheless, epidemiological investigations concerning mild outpatient cases remain scarce, resulting in inadequate descriptions of their clinical, etiological, and epidemiological characteristics. Our study aimed to analyze the clinical, etiological, and epidemiological characteristics of HFMD outpatients in Chengdu from 2019 to 2022 while identifying potential risk factors associated with the progression of outpatients requiring hospitalization. A retrospective study was conducted to summarize the clinical, etiological, and epidemiological characteristics of outpatient HFMD cases in Chengdu from 2019 to 2022. Risk factors associated with progression to hospitalization of HFMD outpatients were evaluated using binomial logistic regression analysis. The study included 1,073 coxsackievirus A6 (CVA6), coxsackievirus A10 (CVA10), and coxsackievirus A16 (CVA16) HFMD nucleic acid test-positive outpatients. Among these, only 45 outpatients (4.19%) progressed to hospitalization. The median ages for CVA6, CVA10, and CVA16 infections were 25.23, 28.13, and 38.45 months, respectively (P < 0.001). CVA6 (76.51%, 821/1,073) has become the main serotype among outpatients in Chengdu, with the proportions from the second half of 2019 to 2022 being 45.59%, 95.17%, 77.67% and 80.71% respectively. EV-A71 cases even disappeared. Patients infected with CVA10 had a significantly higher likelihood of hospitalization (P < 0.05), while the presence of oral rash served as a protective factor (P < 0.05). Our study highlights the critical need for enhanced surveillance of multiple HFMD pathogens, predominantly caused by the prevalent serotype CVA6. Clinically, enhanced surveillance of CVA10 is imperative to mitigate the hospitalization rate associated with HFMD.


  • Open Access

    Association of depression with severe non-alcoholic fatty liver disease: evidence from the UK Biobank study and Mendelian randomization analysis

    by Xiaorui Zhou, Juan Liao, Li Liu, Yajing Meng, Dailan Yang, Xuehong Zhang, Lu Long

    The relationship between depression and severe non-alcoholic fatty liver disease (NAFLD) has not been clearly defined. We conducted a longitudinal cohort study and a two-sample Mendelian randomization (MR) analysis to assess the association of depression with severe NAFLD risk. We used individual data from the UK Biobank study with 481,181 participants, and summary data from published genome-wide association studies. The association between depression and severe NAFLD was assessed using Cox proportional hazards regression analysis. Two-sample MR for depression with NAFLD was conducted, the principal analysis employed the inverse variance weighted (IVW) approach. In the observational study, after a median follow-up of 13.46 years, 4,563 participants had severe NAFLD. In multivariable-adjusted model, participants with depression had an increased risk of severe NAFLD (hazards ratio:1.21, 95% confidence interval (CI):1.09–1.34), as compared to those without depression. In subgroup analyses, the association between depression and severe NAFLD risk was generally observed across different subgroups. For the MR, result also showed that genetically predicted depression was causally associated with a higher risk of NAFLD (odds ratio:1.55, 95%CI:1.10–2.19) in IVW. Our study revealed a prospective association of depression with severe NAFLD, thus potentially necessitating clinical monitoring of individuals with depression for severe NAFLD.